Template-directed dye-terminator incorporation with fluorescence polarization detection for analysis of single nucleotide polymorphisms associated with cardiovascular and thromboembolic disease

Thrombosis Research

Volumn 111, Issue 6, 2003, Pages 373-379

  Freeman, Bradley D ^a   Buchman, Timothy G ^a   Zehnbauer, Barbara A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Coagulation; Myocardial infarction; Single nucleotide polymorphism; Thromboembolism

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; FLUORESCENCE POLARIZATION; GENE AMPLIFICATION; GENOTYPE; HEART INFARCTION; HUMAN; NUCLEIC ACID ANALYSIS; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TEMPLATE DIRECTED DYE TERMINATOR INCORPORATION WITH FLUORESCENCE POLARIZATION DETECTION; THROMBOEMBOLISM;

EID: 0347418176     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.10.001     Document Type: Article

References (20)

1. Nanfro J.J. Anticoagulants in critical care medicine. Chernow B. The pharmacologic approach to the critically ill patient. 3rd ed. 1994;666-684 Williams & Wilkins, Baltimore.
2. Blake G.J., Schmitz C., Lindpaintner K., Ridker P.M. Mutation in the promotor region of the β-fibrinogen gene and the risk of future myocardial infarction, stroke, and venous thrombosis. Eur. Heart J. 22:2001;2262-2266.
3. Iacoviello L., Ci Castelnuovo A., de Knijff P., D' Orazio A., Amore C., Arboretti R.et al. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N. Engl. J. Med. 338:1998;79-85.
4. Kohler H.P., Stickland M.H., Ossei-Gerning N., Carter A., Mikkola H., Grant P.J. Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb. Haemost. 79:1998;8-13.
5. Weiss E.J., Bray P.F., Tayback M., Schulman S.P., Kickler T.S., Becker L.C.et al. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N. Engl. J. Med. 334:1996;1090-1094.
6. Klerk M., Verhoef P., Clarke R., Blom H.J., Kok F.J., Schouten E.G.et al. MTHFR 677C→T polymorphism and risk of coronary heart disease. JAMA. 288:2002;2023-2032.
7. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 88:1996;3698-3703.
8. Ridker P.M., Hennekens C.H., Lindpaintner K., Stampfer M.J., Eisenberg P.R., Miletich J.P. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N. Engl. J. Med. 332:1995;912-917.
9. Kwok P.-Y. High-throughput genotyping assay approaches. Pharmacogenomics. 1:2000;95-100.
10. Hsu T.M., Chen X., Duan S., Miller R.M., Kwok P.Y. Universal SNP genotyping assay with fluorescence polarization detection. BioTechniques. 31:2001;560-570.
11. Hessnes M.J., Budish M.A., Friedman K.D. Genotyping of factor V G1691A (Leiden) without the use of PCR by invasive cleavage of oligonucleotide probes. Clin. Chem. 46:2000;1051-1056.
12. Hessner M.J., Friedman K.D., Voelkerding K.V., Huber S., Ryan D., Nuccie B.et al. Multisite study for genotyping of the factor II (Prothrombin) G20210A mutation by the invader assay. Clin. Chem. 47:2001;2048-2050.
13. Erali M., Schmidt B., Lyon E., Wittwer C. Evaluation of electronic microarrays for genotyping factor V, factor II, and MTHFR. Clin. Chem. 49:2003;732-739.
14. Kwok P.Y. SNP genotyping with fluorescence polarization detection. Hum. Mutat. 19:2002;315-323.
15. Kwok P.Y. Methods for genotyping single nucleotide polymorphisms. Annu. Rev. Genomics Hum. Genet. 2:2001;235-258.
16. Hsu T.M., Chen X., Duan S., Miller R.M., Kwok P.Y. Universal SNP genotyping assay with fluorescence polarization detection. BioTechniques. 31:2001;560-570.
17. Hsu T.M., Law S.M., Duan S., Neri B.P., Kwok P.Y. Genotyping single-nucleotide polymorphisms by the Invader assay with dual-color fluorescence polarization detection. Clin. Chem. 47:2001;1373-1377.
18. Reeder C.E., Dickson W.M. Economic implications of pharmacogenomics. Rothstein M.A. Pharmacogenomics - social, ethical, and clinical dimensions. 2003;229-250 Wiley, Hoboken.
19. Evans W.E., McLeod H.L. Pharmacogenomics - drug disposition, drug targets, and side effects. N. Engl. J. Med. 348:2003;538-549.
20. Weinshilboum R. Inheritance and drug response. N. Engl. J. Med. 348:2003;529-537.